WA
ELV icon

WPG Advisers’s Elevance Health ELV Stock Holding History

WPG Advisers’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.9K Buy
49
+12
+32% +$4.45K 0.01% 565
2026
Q1 		$10.8K Sell
37
-12
-24% -$3.94K 0.01% 647
2025
Q4 		$17.2K Buy
49
+2
+4% +$676 0.01% 549
2025
Q3 		$15.2K Sell
47
-25
-35% -$7.78K 0.01% 575
2025
Q2 		$28K Buy
72
+5
+7% +$2.01K 0.02% 414
2025
Q1 		$29.1K Buy
67
+43
+179% +$17.3K 0.03% 383
2024
Q4 		$8.85K Buy
+24
New +$10K 0.01% 665

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AACR
ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return

WPG Advisers's ELV Position: Q2 2026 in Review

WPG Advisers increased its Elevance Health (ELV) stake by 32% in Q2 2026, buying an estimated $4.45K and bringing the position to 49 shares worth $18.9K. The position accounts for 0.01% of the portfolio, ranked #565.

WPG Advisers first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. The position peaked at $29.1K in Q1 2025. 917 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • WPG Advisers held 49 shares of Elevance Health worth $18.9K as of Q2 2026.
  • WPG Advisers bought 12 Elevance Health shares in Q2 2026, an estimated $4.45K.
  • Elevance Health made up 0.01% of WPG Advisers's portfolio in Q2 2026, its #565 holding.
  • WPG Advisers first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's Elevance Health position peaked at $29.1K in Q1 2025.
  • 917 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.